Share Price, page-13864

I am of the view that Acadia put itself up for sale today with its flashy business and pipeline update with no less than seven bullet points one of which being expected 2025 annual revenue in excess of $1 billion. The company has been around for 30 years and provides a potential acquirer with 30 years of tax losses to utilize, lots of cash on the balance sheet, and all that revenue. Would not be surprised if Acadia becomes a big pharma subsidiary this year. Pfizer picked up Baker Brothers lady big holding SGEN. The business and pipeline update today was the equivalent of Acadia dropping a big juicy worm as bait into a stocked pond. As for Neuren, Jon’s silence is deafening. I hope it’s forced silence due to a potential acquisition, which would also explain Little T joining the witness protection program, and the dramatic halt in the share buyback in the second half of December.